PKI-166 hydrochloride
≥98%
- Product Code: 102077
CAS:
2230253-82-2
| Molecular Weight: | 366.84 g./mol | Molecular Formula: | C₂₀H₁₉ClN₄O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
PKI-166 hydrochloride is primarily used in research settings as a potent and selective inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. Its application is significant in the study of cancer biology, particularly in understanding the role of EGFR in tumor growth and progression. Researchers utilize this compound to investigate the mechanisms of EGFR signaling pathways and to evaluate its potential as a therapeutic target in various cancers, including lung, breast, and colorectal cancers. Additionally, PKI-166 hydrochloride is employed in preclinical studies to assess the efficacy and safety of EGFR inhibitors in animal models, providing valuable insights for the development of targeted cancer therapies. Its ability to inhibit EGFR activation makes it a crucial tool in the exploration of novel treatment strategies for EGFR-driven malignancies.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿17,883.00 |
+
-
|
PKI-166 hydrochloride
PKI-166 hydrochloride is primarily used in research settings as a potent and selective inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. Its application is significant in the study of cancer biology, particularly in understanding the role of EGFR in tumor growth and progression. Researchers utilize this compound to investigate the mechanisms of EGFR signaling pathways and to evaluate its potential as a therapeutic target in various cancers, including lung, breast, and colorectal cancers. Additionally, PKI-166 hydrochloride is employed in preclinical studies to assess the efficacy and safety of EGFR inhibitors in animal models, providing valuable insights for the development of targeted cancer therapies. Its ability to inhibit EGFR activation makes it a crucial tool in the exploration of novel treatment strategies for EGFR-driven malignancies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :